Magenta Medical to Commercialize New Surgical Membrane Products
7/11/2012 10:08:01 AM
BIRMINGHAM, Ala.--(BUSINESS WIRE)--Magenta Medical Inc. has been incorporated to manufacture a new type of surgical membranes, which are routinely used by physicians and dentists to separate tissues and to provide support during wound healing. The proprietary membranes are composed of dense chitosan, a natural and non-toxic sugar polymer that is typically prepared from the chitin shells of shrimp. The innovative technology is patent pending and was developed by Agenta Biotechnologies Inc. (www.agentabio.com), located in Birmingham’s Innovation Depot. The first publication of the new membrane technology is in press in the Journal of Biomaterials Science, Polymer Edition (www.tandfonline.com/toc/tbsp20/current).